Compare Limas Indonesia Makmur Tbk (LMAS) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Limas Indonesia Makmur Tbk vs Merck Tbk. — how do they compare? Limas Indonesia Makmur Tbk trades at Rp50 (market cap 39.39B), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Merck Tbk. is far larger — about 44.7× Limas Indonesia Makmur Tbk's market cap. Which is the better fit depends on your goals.
| LMAS | MERK | |
|---|---|---|
Market Cap | 39.39B | 1.76T |
Volume | — | 63K |
Lot | — | 630 |
Turnover | — | 243.97M |
Average Price | — | 3,872.46 |
Value | — | 243.97M |
Indicative Equilibrium Price | — | 3,900 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Limas Indonesia Makmur Tbk
Based in Jakarta and established on June 4th 1996, Limas offers comprehensive financial information services for the financial sector. On 3rd quarter of 1999, S&P Comstocks, Inc appointed the Company as its strategic partner for its data distribution agent in Indonesia. On November 1999, the Company launched its first real time terminal product called StockWatch with extensive tools and coverage for trading on Jakarta Stock Exchange. On January 2000, Limas received endorsements from the Jakarta Stock Exchange to provide its members with the StockWatch terminal. Further endorsements were followed subsequently from Surabaya Stock Exchange to its members on March 2000. On June 2000, the Company launched www.e-bursa.com the first financial sites in local language bahasa. On December 2000, Limas partnered with Dow Jones Newswire to launch the first real time news in bahasa called Dow Jones Limas news. On September 2001, StockWatch version 2.1 was launched and was the first realtime terminal to provide live coverage on Futures trading on the Surabaya Stock Exchange.
Read more on LMAS →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
